Lv2
180 积分 2022-12-02 加入
Characterization of an anti-STEAP1 T-Cell Dependent Bispecific Antibody for the Treatment of Prostate Cancer and Associated Toxicity in Cynomolgus Monkeys
10天前
已完结
Hallmarks of cancer—Then and now, and beyond
17天前
已完结
Inhibitory PD-1 axis maintains high-avidity stem-like CD8+ T cells
2个月前
已完结
Selectivity Approaches in Therapeutic Antibody Design
3个月前
已完结
Unveiling conformation-selective regulation of the norepinephrine transporter
3个月前
已完结
Development roadmap for subcutaneous delivery of high dose biologics - high concentration formulation, analytical comparability and patient preference considerations for large volume devices
3个月前
已完结
Folding-mediated secretion of pure bispecific antibodies
4个月前
已完结
Regulatory T cells in the tumour microenvironment
4个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
4个月前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
6个月前
已完结
皖公网安备34019202002308
